Using VCaP and 22Rv1 cells, PCa cell lines expressing SRRM4, SRRM4 ASO successfully reduced SRRM4 expression and cell viability in a dose-dependent manner through changing REST splicing similar to that in SCLC cells (Figs. 1 and 4). This evidence concerns the gene SRRM4 and small cell lung carcinoma.